What is Michael W Goodman, MD?
Michael W Goodman, MD operates as a premier board-certified gastroenterology practice, providing critical diagnostic and therapeutic interventions for complex digestive disorders. The clinic maintains a robust market position by integrating advanced medical technology with patient-centric care, focusing on conditions of the esophagus, stomach, intestines, colon, liver, and pancreas. Their service portfolio includes high-demand procedures such as colonoscopies, flexible sigmoidoscopies, and specialized infusion therapies for chronic conditions like Crohn's disease. Through its commitment to state-of-the-art facilities and a highly skilled clinical team, the practice serves as a cornerstone of digestive health in Tennessee, ensuring high-quality outcomes for a diverse patient demographic.
How much funding has Michael W Goodman, MD raised?
Michael W Goodman, MD has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Michael W Goodman, MD
PPP
Public-Private Partnership
What's next for Michael W Goodman, MD?
With the successful acquisition of this late-stage capital, the practice is poised to accelerate its growth trajectory through infrastructure modernization and service line diversification. The strategic allocation of these funds will likely focus on upgrading diagnostic equipment and expanding the capacity for infusion therapies, which are essential for managing chronic gastrointestinal diseases. As the healthcare landscape shifts toward more integrated, technology-driven patient care, Michael W Goodman, MD is well-positioned to scale its operations, improve patient throughput, and solidify its reputation as a leader in regional gastroenterology. Future initiatives will likely prioritize the optimization of clinical workflows and the potential expansion of specialized treatment programs to meet the increasing demand for high-acuity digestive health services.
See full Michael W Goodman, MD company page
